Mid Cap Stocks At 52-Week Highs: Monday’s Full List
A small list of new highs is heavily concentrated in one part of the market, but the business results underneath are far from uniform.
The strongest one-month run on today’s list belongs to 10x Genomics (TXG), up 36.5% while the S&P 500 has returned -0.5% over the last month. As of Monday, September 28, there are 6 Mid Cap US and Canada-listed stocks in the Trefis coverage universe trading at their 52-week highs.
The list is heavily concentrated, with 5 of the names belonging to the Health Care sector. When a stock’s price is at a yearly high, does the underlying business always match the new level?
The Full List, Largest First
The table below lists all 6 names this screen surfaced, largest first, with one-day, one-week, one-month, and one-year returns:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| BIIB | $33.78 Bil | 0.5% | 4.4% | 3.2% | 68.6% |
| MTD | $31.09 Bil | 2.2% | 8.0% | 9.8% | 27.8% |
| VTRS | $21.25 Bil | 2.5% | 6.8% | 8.2% | 99.3% |
| TXG | $11.5 Bil | 3.3% | 11.9% | 36.5% | 640.6% |
| RGEN | $10.95 Bil | 2.3% | 7.4% | 6.6% | 59.5% |
| MSGS | $10.06 Bil | 3.4% | 4.1% | 5.8% | 87.6% |
This screen covers US and Canada-listed stocks in the Trefis coverage universe. Mid Cap here means a market value between $10 billion and $40 billion, the upper figure excluded.
A stock’s price run can detach from its recent business results.
The 36.5% one-month gain for 10x Genomics (TXG) is a clear example. The company’s revenue declined 4.3% over the last twelve months, and its operating margin was -14.9%.
In contrast, Mettler-Toledo International (MTD) also reached a new high. It trades at 34.3 times trailing earnings, and its revenue grew 6.9% over the last twelve months, and its operating margin was 28.4%.
A 52-week high is a starting point for questions, not an answer.
Strength in a stock’s price can persist. But a new high is a data point about price, not a final verdict on a business.
The disciplined move is to look past the price and ask if the business fundamentals can earn the valuation.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks.
New Highs Fade. Discipline Compounds
Some of the names on this list will keep setting highs for years, and some are at the top of their run right now. Sorting one from the other, name by name, every day, is the work most investors never keep up with.
That sorting is what the Trefis High Quality (HQ) Portfolio does systematically: about 30 quality businesses screened for the fundamentals that sustain a run, held with rules instead of excitement. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Use the high list for ideas; use the portfolio for the compounding.